FDA In Brief: FDA approves new packaging for brand-name over-the-counter loperamide to help curb abuse and misuse

FDA-TRACK: Prescription Drug User Fee Act Review Goals Summary

Alembic Pharmaceuticals Limited – 02/06/2021. Country: India. Record Type: 483

Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 08/08/2025
Short Title (70 char) Olympia Pharmaceuticals. Orlando, FL. 483 issued 08/08/2025
FEI Number 3009724085
Firm Name Olympia Pharmaceuticals
Record Type 483
State FL
Establishment Type Outsourcing Facili

Unapproved New Drugs/Misbranded

Establishment registration and drug listing data is submitted by drug manufacturers and own label drug distributors through electronic means using Structured Product Labeling format (SPL).

Innovative drugs often mean new treatment options for patients and advances in health care for the American public.